Jafron Biomedical Co., Ltd. is a high-risk healthcare company in China specializing in the research, development, and sales of biomaterials and medical devices. They focus on offering ESG-friendly solutions for kidney disease, poisoning, critical illness, and liver disease. Some of their key products include the JFYC-100 pre-punching machine, DX-10 blood purifier, and HA resin hemoperfusion. With an ESG score of 31.1, Jafron Biomedical Co., Ltd. is at the forefront of sustainability and environmental governance in the healthcare industry.